Skip to main content
An official website of the United States government

Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Please check the “Other Notices” tab on the NIH Guide for Grants and Contracts to see updates to NIH policies that ensure alignment with the Administration’s priorities.

Parent Announcements (For Unsolicited or Investigator-Initiated Applications)

Parent announcements are broad funding opportunities that applicants can use to submit investigator-initiated applications for a range of popular programs. These announcements do not specify any particular area of scientific interest. They simply provide the standard forms and instructions needed to apply. Parent announcements are open for up to three years and are typically reissued to ensure continuity. They use standard due dates with three application, review, and award cycles each year.

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Sort descending Program Official
Enhancing Mechanistic Research on Precision Probiotic Therapies PAR-25-211 (R61/R33 Clinical Trial Optional) R61, R33 Clinical Trial Optional 06/03/2027 Gabriela Riscuta, M.D., CNS
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research PAR-25-248 (U01 Clinical Trial Not Allowed) U01 Clinical Trial Not Allowed 10/09/2027 Claire Zhu, Ph.D.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-25-104 (R34 Clinical Trials Optional) R34 10/26/2027 Goli Samimi, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-25-103 (U34 Clinical Trials Optional) U34 10/26/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Notice of Correction to PAR-25-104, Cancer Prevention and Control Clinical Trials Planning Grant Program NOT-CA-25-023 (R34 Clinical Trials Optional) R34 10/26/2027 Goli Samimi, Ph.D., M.P.H.
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-25-043 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/08/2028 Edward Sauter, M.D., Ph.D.
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-25-044 (R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 01/08/2028 Edward Sauter, M.D., Ph.D.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-25-145 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/08/2028 Rachel Altshuler, Ph.D.
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk NOT-CA-25-002 01/08/2028 Edward Sauter, M.D., Ph.D.